ICAD INC

Action Icad (ICAD)

Entreprise du secteur de la santé. Voici le cours, un aperçu de l'activité et l'essentiel à savoir sur Icad en juin 2026.

iCAD, Inc. provides artificial intelligence-powered cancer detection. Its ProFound Breast Health Suite enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Cancer Detection segment solutions include advanced artificial intelligence and image analysis workflow solutions that enable healthcare professionals to serve patients by identifying pathologies and pinpointing the prevalent cancers earlier, a range of upgradeable computer-aided detection systems and workflow solutions for digital breast tomosynthesis, full-field digital mammography, magnetic resonance imaging and computed tomography. ProFound Suite offers 360-degree solutions for cancer detection, density assessment, and personalized risk evaluation, all based on a two-dimensional or three-dimensional mammogram’s collection of images. ProFound Density Assessment standardizes and simplifies breast density reporting and algorithmically examining.

Aperçu de la performance de l'action

Conserver

Note des analystes

Analysts suggest holding ICAD's stock with a target price of $4.38, indicating potential growth.

Au-dessus de la moyenne

Santé financière

ICAD INC shows strong revenue and profit margins, with solid cash flow per share indicating financial stability.

Source : le sentiment des analystes est fourni par Refinitiv Ltd, un leader mondial des données de marchés financiers comptant plus de 40 000 clients professionnels. Refinitiv Ltd est un tiers indépendant de Nemo. Ceci ne constitue pas un conseil.

Découvrir plus d'opportunités

ABT

Abbott

Conçoit, fabrique et commercialise une gamme de produits de santé.

A

AGILENT TECHNOLOGIES INC

Agilent Technologies est un leader mondial dans la recherche en sciences de la vie et le diagnostic. Révision PO.

ALGN

ALIGN TECHNOLOGY INC

Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.

Paniers incluant ICAD

Healthcare's Efficiency Imperative

Healthcare's Efficiency Imperative

UnitedHealth Group's recent profit miss, driven by high medical costs, has triggered a major cost-cutting initiative across the company. This move signals a broader industry trend, creating an investment opportunity in companies that provide AI and technology solutions to help healthcare organizations improve efficiency and reduce operational expenses.

Publié: 30 juillet 2025

Explorer le panier

Pourquoi investir avec Nemo ?

Nemo Logo Fade
🆓

Zéro commission

Négociez actions, ETF et plus encore sans commission. Gardez une plus grande part de vos gains.

🔒

Fiable et réglementé

Membre du groupe Exinity depuis 2015, au service de plus d'un million de clients dans le monde.

💰

6 % d'intérêts sur les liquidités

Gagnez 6 % de TAEG sur les liquidités non investies, avec des intérêts versés quotidiennement.